145
Participants
Start Date
August 1, 2020
Primary Completion Date
August 7, 2024
Study Completion Date
July 9, 2026
SQ3370
SQ3370 consists of 2 components: SQL70, a protodrug-activating biopolymer, and SQP33, a protodrug of Doxorubicin
RECRUITING
Chris O'Brien Lifehouse, Camperdown
RECRUITING
Royal North Shore Hospital, Sydney
RECRUITING
Cancer Research Institute, Adelaide
RECRUITING
Washington University in St. Louis, St Louis
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
Sarcoma Oncology Center, Santa Monica
RECRUITING
City of Hope, Duarte
RECRUITING
Stanford Cancer Center, Palo Alto
RECRUITING
Oregon Health & Science University, Portland
RECRUITING
University of Washington, Seattle
Shasqi, Inc.
INDUSTRY